Osiris Drug's Failure Was Easy to Envision
Osiris Therapeutics' shoddy work and shortcuts in its previous clinical trials for stem cell drug Prochymal led to the failure of two late-stage trials.
11:37AM 09/08/09
TSC Ratings' Updates: Cablevision
By TheStreet.com Ratings Staff
Cablevision is upgraded; Foundry, Kyocera, L-3 and Morningstar are downgraded.
05:31PM 11/17/08
The Good, the Bad and the Short (Biotech Select $)
Updates include both positive and negative news. Plus, more details on the most recent addition to the model portfolio.
09:19AM 11/12/08
Ansys Shoots Higher on Profit Jump
The software maker surpasses analysts' estimates.
10:46AM 11/06/08
Chesapeake Insider Sells $569M Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:15AM 10/13/08
Recently laid off? Worried you may be next? Sandy Gross, executive recruiter at Pinetum Partners, offers job-finding strategies suited for these turbulent times.
12:59PM 10/04/08
By TheStreet.com Ratings Staff
Intel, DreamWorks, Valley National, Jones Lang Lasalle and TransAlta have their ratings changed.
12:05PM 08/13/08
Stockpickr's Activist Track Stocks
Large shareholders are clamoring for change at these companies; their bets may be worth piggybacking.
10:17AM 05/21/08
TSC Ratings' Upgrades, Downgrades: Comcast
By TheStreet.com Ratings Staff
Comcast, Ikon Office Solutions, PS Business Parks, Conex upgraded; Advisory Board downgraded.
06:45AM 05/19/08
The latest positive data are borne of earlier negative results.
06:13AM 11/28/07
Dip Provides Entry in Dassault Systemes (RealMoney.com $)
The stock took a hit last Wednesday after earnings, and this looks like a buy point.
04:14PM 11/05/07
Osiris Stem Cells Safe for Heart Injury
A phase I study suggests that adult stem cells might have a future as a heart-repairing therapy.
01:25AM 06/20/07
Tuesday's Late Winners & Losers
Yahoo! slumps after posting a first-quarter revenue miss.
08:55PM 04/17/07
Osiris Therapeutics Takes a Bumpy Ride
It won't be a smooth road for this stem-cell therapy developer.
02:38PM 02/14/07



Connect with TheStreet